The Effect of Progressive Relaxation and Breathing Exercise on Sleep Quality and Exercise Self-Efficacy in Patients With COPD

May 25, 2022 updated by: Kevser Sevgi Ünal Aslan, Osmaniye Korkut Ata University

Aim: This study was conducted to determine the effect of progressive muscle relaxation and breathing exercise on sleep quality and exercise self-efficacy in chronic obstructive pulmonary patients.

Methods: This study was conducted as a randomized controlled experimental study. The study was conducted with 64 chronic obstructive pulmonary patients, where 36 of them were in the intervention group and 34 in the control group. Data of the study were collected using the descriptive information form, the Pittsburgh Sleep Quality Index, and the Exercise Self-Regulatory Efficacy Scale (Ex-SRES) for patients with COPD.

Results: When the total scores pertaining to the sleep quality index and exercise self-efficacy of the individuals in the intervention and control groups were compared, it was found that there were statistically significant differences in the intervention group compared to the control group (p < 0.05).

Keywords: Exercise Self-Regulatory Efficacy, sleep quality in patients with COPD, PGE along with breathing exercises, pulmonary rehabilitation

Study Overview

Study Type

Interventional

Enrollment (Actual)

64

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Aksaray, Turkey
        • Aksaray University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 90 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • were to be 18 years of age or older
  • not using sleeping pills
  • verbally stating that they have moderate and severe sleep disorders.

Exclusion Criteria:

  • having any lung disease other than COPD
  • having cardiological problems (heart failure, uncontrollable hypertension, history of angina and myocardial infarction, heart valve problems), psychotic disorder,
  • inability to communicate verbally and having hearing problems.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Single Group Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: experimental group
progressive muscle relaxation exercises + breathing exercise
progressive muscle relaxation+breathe exercises
Experimental: control group
only breathing exercise
breathe exercises

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
progressive muscle relaxation exercises changes sleep quality and exercise self-efficacy.
Time Frame: 1 mounth
Sleep quality will be assessed using the Pittsburgh Sleep Quality Index as an pre- test and 4 weeks later as a post-test test.
1 mounth

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
progressive muscle relaxation exercises with breathing exercise changes sleep quality and exercise self-efficacy.
Time Frame: 1 mounth

Sleep quality will be assessed using the Pittsburgh Sleep Quality Index as an pre-test and 4 weeks later as a post-test.

.The Exercise Self-Regulatory Efficacy Scale will be used as a pre-test and after 4 weeks as a post-test to measure the exercise capacity of COPD patients.

1 mounth

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2021

Primary Completion (Actual)

July 1, 2021

Study Completion (Actual)

October 1, 2021

Study Registration Dates

First Submitted

May 20, 2022

First Submitted That Met QC Criteria

May 25, 2022

First Posted (Actual)

May 31, 2022

Study Record Updates

Last Update Posted (Actual)

May 31, 2022

Last Update Submitted That Met QC Criteria

May 25, 2022

Last Verified

May 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

may be published at the discretion of the authors, provided appropriate justifications are provided.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on COPD Asthma

Clinical Trials on progressive muscle relaxation+breathe exercises

Subscribe